Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 2010 results found since Jan 2013.
Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer
As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects.
On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week.
Related: Emergency Considerations in COVID-19 Vaccine Administration
In the U.S., vaccine recipients are supposed ...
Source: JEMS Operations - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news
Neurological Immune Related Adverse Events Post-COVID-19 Vaccination: A Systematic Review
This article is protected by copyright. All rights reserved.PMID:34921562 | DOI:10.1002/jcph.2017
Source: The Journal of Clinical Pharmacology - December 18, 2021 Category: Drugs & Pharmacology Authors: Ameena Shafiq Mohammad A Salameh Ibrahim Laswi Ibrahim Mohammed Omar Mhaimeed Nada Mhaimeed Narjis Mhaimeed Pradipta Paul Malik Mushannen Abdallah Elshafeey Ahmed Fares Sean Holroyd Dalia Zakaria Source Type: research
Post-licensure zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in older adults: a systematic review and meta-analysis
This study is registered on PROSPERO, CRD42021232383.FINDINGS: Our search identified 1240 studies, of which 1162 were excluded based on title and abstract screening. A further 56 articles were excluded on reading the full text. 22 studies (21 cohort studies and one case-control study, involving 9 536 086 participants and 3ยท35 million person-years in the USA, UK, Canada, and Sweden) were included in the quantitative analysis. Of these, 13 articles were included in the meta-analysis. The overall quality of evidence was very low for all outcomes. The pooled vaccine effectiveness for ZVL against herpes zoster in adults was 45...
Source: Herpes - September 13, 2022 Category: Infectious Diseases Authors: James F Mbinta Binh P Nguyen Prosper Mandela A Awuni Janine Paynter Colin R Simpson Source Type: research
COVID-19 Vaccine-Associated Ocular Adverse Effects: An Overview
CONCLUSIONS: Evidence regarding the ocular adverse effects does not outweigh the benefits of SARS-CoV-2 vaccination in patients with pre-existing systemic or ophthalmic diseases. This review provides insights into the possible temporal association between reported ocular adverse events and SARS-CoV-2 vaccines; however, further investigations are required to identify the link between potential causality and pathological mechanisms.PMID:36366386 | DOI:10.3390/vaccines10111879
Source: Herpes - November 11, 2022 Category: Infectious Diseases Authors: Parul Ichhpujani Uday Pratap Singh Parmar Siddharth Duggal Suresh Kumar Source Type: research
COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses Infections
Vaccines (Basel). 2023 Jan 20;11(2):232. doi: 10.3390/vaccines11020232.ABSTRACTThere are several human herpesviruses. A common characteristic of infection by these viruses is latency, by which the virus assumes a non-replicative state, subverting the attentions of the host's immune response. In immunocompetent hosts, herpesviruses are immunologically controlled, although periodic virus shedding can occur. In situations where immunological control is lost, herpesviruses can reactivate and produce clinically apparent disease. It is now becoming apparent that COVID-19 or exposure to COVID-19 vaccines can exert several effects...
Source: Herpes - February 28, 2023 Category: Infectious Diseases Authors: Peter A C Maple Source Type: research
Recombinant zoster vaccine coverage in the United States: An analysis of claims-based data
This study quantifies RZV coverage and assesses predictors for RZV vaccination using a U.S. claims database. Univariate linear regression provided annual prevalence of RZV vaccination and multivariable logistic regression provided ORs and 95% CIs for associations between predictors and RZV vaccination. A total of 4,124,315 individuals (19,080,914 person-years) were included in this study. Since receiving FDA approval for the prevention of HZ, RZV coverage (of at least one dose) has reached approximately 17% within the eligible U.S. population by January 2021, although significant disparities between demographic groups were...
Source: Vaccine - May 7, 2023 Category: Allergy & Immunology Authors: Chad Y Lewis Kunal Mishra Yuwei Sun Samantha J Sechrist Benjamin F Arnold Nisha R Acharya Source Type: research
